Skip to content

The talk about RB

Who is saying what about RB? Here's a selection of some of the RB stories making the news.

Strong healthcare brands boost Reckitt Benckiser sales
"RB reported forecast-beating quarterly sales thanks to a strong performance from its high-margin healthcare and hygiene brands, and growth across all geographical regions."
Financial Times, 24 April 2015
> Read full article

"As part of a “Stop Diarrhoea” program run by the non-profit Save the Children, a biodegradable toilet powder that speeds up the breakdown of excrement has been developed by RB — makers of toilet cleaning products such as Harpic and Dettol."
Wall Street Journal, 26 March 2015
> Read full article

“'The consumer healthcare landscape is going to change enormously in the next 10 years. What you see today is not what you will see tomorrow,' according to Sharon James, head of research and development at RB."
OTC Bulletin, 7 November 2014
> View full article (PDF)
"Mr Kapoor said he expected margins to rise in the second half and full- year targets to be hit, with revenue at the 'lower end' of the 4pc to 5pc forecast range. RB remains a massive player in its core businesses and has the brands, management and expertise to strengthen its place in the sector along with the financial firepower to back this."
Daily Telegraph, 22 October 2014 (print edition)

Ditching the drugs puts focus on health
"Third-quarter figures give a clear enough idea why the pharmaceuticals business is being spun off, allowing RB to concentrate on higher-growth health brands, such as Nurofen and Scholl."
The Times, 22 October 2014
> Read full article

How RB became 'digital at heart'
Marketing chief Laurent Faracci details how interactive affects everything from RB's agency relationships to how it recruits executives and works with retailers.
Advertising Age, 16 September 2014
> Read full article

RB boss makes his name with Mucinex and K-Y Jelly
"Kapoor has outlined a strategy of expanding sales of over-the-counter brands such as Mucinex decongestants and Durex condoms. While that business accounted for a quarter of 2011 sales – about the same as the unit that includes laundry products – consumer health has better prospects. The $200 billion industry is expanding fast due to increasing self-medication among an aging population and drugs moving off prescription."
Bloomberg, 18 August 2014
> Read full article

Durex India launches initiatives to address the taboo subject of sexual wellbeing
""In an environment where sex is not discussed candidly, there is a need of having an easily accessible source of credible information, which helps consumers understand this space better," said Chander Mohan Sethi, SVP South East Asia. To that effect, Durex India recently launched an online store where people can go and buy condoms without feeling embarrassed at the counter. "The content is useful, not only for couples looking to revive their relationship, but also for teenagers explor­ing their sexuality," Sethi explained."
Time Out Mumbai, 28 February 2014
> Read full article 

Maker of brands including Dettol and Nurofen expects revenues to rise as firm increases sales of its 19 'Powerbrands'
"Announcing its full-year results for 2013, RB posted like-for-like sales, excluding drugs, up 4% in the fourth quarter, slightly less than the 4.2% rise forecast by analysts. Including revenue from acquisitions, sales were up 7% – ahead of the company's target.

Chief executive Rakesh Kapoor said he expected revenues, excluding drugs sales, to rise between 4% and 5% in the current year as the company increases sales of its 19 so-called powerbrands such as Harpic, Vanish and Strepsils."
The Guardian, 12 February 2014
> Read full article

"RB has pegged its future on health and hygiene, saying higher growth products such as vitamins and branded medicines had helped push sales above €10bn for the first time in 2013."
Financial Times, 12 February 2014
> Read full article

RB shrugs off fears for emerging markets slowdown
"Stripping out the pharmaceuticals arm, operating profits rose 7% to £2.19 billion on revenue of £10 billion. Highlighted as strong performers were both its health and hygiene arms. In health, brands such as Durex, Nurofen, Scholl footcare and Gaviscon did well, although Strepsils and Mucinex performed less well against tough comparatives a year earlier. In hygiene, it was Veet, Dettol and Lysol that did best, particularly in the last quarter of the year.

Credit Suisse analysts were impressed with the numbers, saying they were a “modest beat” on expectations. In a note to clients, they wrote: “A case of Reckitt beginning to rediscover its mojo?”"
London Evening Standard, 12 February 2014
> Read full article

RB sees more sales growth, names chairman for pharma unit

"RB, whose wide range of household, health and personal brands include Lysol disinfectant and Durex condoms earlier reported that fourth-quarter like-for-like sales excluding its drug business rose 4 percent. The consensus forecast from analysts in a company-supplied survey was for an increase of 4.2 percent."
Reuters, 12 February 2014
> Read full article

Durex 'Fundawear' named by Wired as 'need to know' tech trend for 2014
The RB brand's controllable vibrating underwear, ‘Fundawear’, has been highlighted by tech magazine Wired as a ‘need to know’ tech trend for 2014. "Fundawear has had more than 8.5 million YouTube views, $2m worth of free media, over 12,000 news and blog articles and a 4000% increase in Facebook fan growth rate, equating to a 35:1 return on investment."
The Drum, 25 November 2013
> Read full article

RB enjoys double-digit Health gain
"'If you look at our Health performance, all of our key brands have done very well,' said Rakesh Kapoor, RB's CEO. Increased sales of RB's Powerbrands – in particular Durex, Mucinex, Nurofen and Scholl – had been driven by continued investment and brand innovation. During the quarter, the Mucinex brand had been expanded beyond cough and congestion, Kapoor noted, with the launch of Mucinex Fast Max Night-Time Cold & Flu. Brand innovations at Durex in the three months had included 'Real Feel' polyisoprene condoms and Durex Embrace gels. These new products were helping Durex become a 'sexual wellbeing brand'."
OTC Bulletin, 8 November 2013

RB points to brand building and innovation for revenue lift
Rakesh Kapoor, chief executive officer, says: “RB’s focus on health and hygiene and emerging markets, along with our move to drive growth in ENA through increased investment behind innovations and a streamlined organisation structure is delivering good results.”"
Marketing Week, 22 October 2013
> Read full article

RB boosted by emerging markets
"In July, saying it expects revenue growth at the upper end of 5%-6% range, while maintaining adjusted operating margins. Chief Executive Rakesh Kapoor said: "We all know that market conditions remain challenging, but I am confident that our strategy for growth and outperformance underpinned by our commitment to invest for the long term is the right thing to do.""
Market Watch, Wall Street Journal, 22 October 2013
> Read full article

RB logs rising quarterly revenues
British household goods firm RB said on Tuesday that third-quarter sales rose five percent, driven partly by emerging markets, and raised its full-year guidance. Revenues climbed to £2.55 billion ($4.1 billion, 3.0 billion euros) in the third quarter of the year, compared with the same part of 2012, [RB] said in a results statement.
Zee News, 22 October 2013
> Read full article

"Every day was something new. Not one day was boring."
"In 2011, Thomas Kappen was an accomplished young professional, but he was ready for a career change… He considered how his skills – negotiation, process improvement and supplier management, to name a few – could transfer to a new field with the help of a new degree…

He recently completed an internship at the consumer product company RB, where he worked as a purchasing intern.

The 10-week gig left him with an experience typical of the supply-chain management field: "Every day was something new," he says. "Not one day was boring.""
3 Things to Know About an MBA in Supply Chain Management
US News, 19 September 2013
> Read full article

CEO Kapoor brings own brand of change to RB
"Under [Rakesh Kapoor's] watch, RB bought U.S.vitamin maker Schiff Nutrition for $1.4 billion, licensed some Bristol-Myers Squibb brands in Latin America, declared a focus on a number of "powerbrands", and moved more managers to emerging markets, where Kapoor knows the challenges firsthand.
Reuters, 15 September 2013
> Read full article

Thrifty spending habits seen dying hard even as economy lifts
"[RB] Chief Executive Rakesh Kapoor told the Reuters summit the recession had prompted his company to do more testing of product innovations in emerging economies like Brazil and then roll them out to mature markets, reversing the usual trend.

"At this point of time, people will think about value in a much more holistic way. They look at price points and benefits in combination," he said. "So you lower the price, improve benefits and it is very appealing for consumers.""
Reuters, 12 September 2013
> Read full article

RB hungry for new health deals
"Consumer health is one of the most fragmented markets in the world, and that is a real issue-stroke-opportunity," Kapoor said. "This fragmentation will result in consolidation - the only question is who, when and how."
Reuters, 11 September 2013
> Read full article

RB upbeat as brands perform well
"[RB] said a strong performance from its Durex condom brand was supported by 'creative digital communications across the world', particularly in China, which is now the largest market for the brand in the world."
The Guardian, 29 July 2013
> Read full article

RB's focus on health pays off
"We continue to face challenging market conditions," said Chief Executive Rakesh Kapoor. "I am pleased that our strong focus on Health & Hygiene Powerbrands is working and our improved company growth rates confirm that we are making the right strategic choices."
Wall Street Journal, 29 July 2013
> Read full article

RB keen to clean up with shift in focus
"Rakesh Kapoor, the chief executive, gave a confident outlook for the full year, when the group expects to hit the top end of revenue forecasts."
The Times, 30 July 2013 
> Read full article (requires subscription)

RB forecasts growth at upper end of targets
"Rakesh Kapoor said: 'Health and hygiene are faster-growing markets [than other categories] . . . our improved company growth rates confirm that we are making the right strategic choices.'"
Financial Times, 29 July 2013
> Read full article (requires subscription)

RB pours focus on water use in developing world
"RB has vowed to switch the onus of its sustainability strategy more towards saving water in developing countries, after a report showed the impact of hand washing in developing countries outweighed that of modern machinery in the west."
The Grocer, 4 June 2013
> Read full article

"Medicine and condoms gives Reckitt [Benckiser] a lift"
The Independent, 22 April 2013
> Read full article

"RB Group Plc, the maker of Dettol handwash, said it remains confident of achieving full-year goals after ... it post[ed] the strongest first-quarter revenue growth in four years."
Businessweek, 22 April 2013
> Read full article

"Reckitt [Benckiser] has made a good start to the first quarter 2013..."
City AM, 22 April 2013
> Read full article

> View older articles

Get involved with RB

  • facebook
  • Linked In
  • twitter
  • You Tube
  • Google Plus
  • blog
  • fmcg

UK's Most Admired Companies Winner 2014/15
We maintain a long running partnership with RB in automatic dishwashing because we know the market leaders also excel in innovations - Christoph Kilian, VP Product Marketing, Product Area, Dishwasher, Bosch and Siemens, Homeappliances GroupThe company (shows) an amazing contrast to its most important competitors...Proctor and Gamble (and) Unilever We work together with RB because RB is a very innovative company and it's ideas are driven by consumer insights- Filip Francke, Head of Product Line Dish Care, Electrolux Home Products, Coporation NV
  • Lysol
  • Mucinex
  • Frenchs
  • Airwick
  • Nurofen
  • Vanish
  • Durex
  • Clearasil
  • Dettol
  • Cillet Bang
  • Strepsils
  • Scholl
  • Gaviscon
  • Mortein
  • Woolite
  • Veet
  • harpic
  • Calgon
  • Finish

This site uses cookies. By continuing to browse the site without disabling them, you consent to our use of cookies. To learn more about the types of cookies we use, please view our cookie policy.

Continue using the site